Context Capital Management’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-149,800
Closed -$1.5M 386
2022
Q4
$1.5M Hold
149,800
0.11% 175
2022
Q3
$1.47M Hold
149,800
0.1% 242
2022
Q2
$1.47M Hold
149,800
0.1% 252
2022
Q1
$1.46M Hold
149,800
0.1% 283
2021
Q4
$1.46M Hold
149,800
0.11% 244
2021
Q3
$1.45M Buy
+149,800
New +$1.45M 0.15% 181

Other funds holding AONC

Context Capital Management's AONC Position: Q1 2023 in Review

Context Capital Management sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 149,800 shares — an estimated $1.5M sold.

Context Capital Management first reported a position in AONC in Q3 2021 and held it in 6 quarters. The position peaked at $1.5M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Context Capital Management reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Context Capital Management sold 149,800 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $1.5M.
  • Context Capital Management first reported a position in American Oncology Network, Inc. Class A Common Stock in Q3 2021 and held it in 6 quarters.
  • Context Capital Management's American Oncology Network, Inc. Class A Common Stock position peaked at $1.5M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Context Capital Management's 13F filing for Q1 2023, filed 8 May 2023.